The increasing understanding of disease-associated genetic pathways is creating new opportunities for antisense and RNAi-based treatments. Researchers can target specific RNA molecules involved in disease mechanisms, supporting the development of therapies directed toward previously challenging biological targets. The Antisense and RNAi Therapeutics Market is emerging as a significant segment...